Considering switching to DrugPatentWatch? See why others have come to us. Switch to DrugPatentWatch
The post DrugPatentWatch Alternatives appeared first on DrugPatentWatch – Make Better Decisions.
This paper was originally published by Ingrid Freije, Stéphane Lamouche, and Mario Tanguay in Therapeutic Innovation & Regulatory Science under a Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/…
Generic drug makers must tailor European market entry strategies to each country. Moreover, they must address the sequence in which they want to enter markets.
The post Generic Drug Market Entry in Europe: Why a Tailored Approach Is Best appeared first…
Generic Drug Market Entry in Europe: Why a Tailored Approach Is Best Read Post »
BIO Attendees – Get a free preview of our book when it launches on July 1st Name Email HP Make Better Decisions helps generic and branded companies alike find and evaluate…
The post Make Better Decisions: Finding and Evaluating Generic and Branded Drug…
Drug patent expiration doesn’t always mean generics enter the market right away. Many factors affect generic drug launches and drug formulary changes.
The post Formulary Management and LCM Patent Strategies: A Complex Interaction appeared first on Drug…
Formulary Management and LCM Patent Strategies: A Complex Interaction Read Post »
There’s no reason to assume that every branded drug will fall victim to the “patent cliff.” Actions taken before drug patent expiration can extend drug life cycles.
The post 5 Steps to Take When Your Drug Patent is About to Expire appeared first on Dru…
5 Steps to Take When Your Drug Patent is About to Expire Read Post »
Artificial intelligence is allowing chemists to find new way to synthesize drug molecules, and forcing drug developers to shore up their patent strategies.
The post Will AI Help Challenge Drug Patents, or Strengthen Them? appeared first on DrugPatentWa…
Will AI Help Challenge Drug Patents, or Strengthen Them? Read Post »
Recently a presentation by an Israeli patent examiner was brought forward in an argument against patent evergreening. In her presentation, the patent examiner claims that patent evergreening has the following…
The post Does Drug Patent Evergreening Pre…
Does Drug Patent Evergreening Prevent Generic Entry? Read Post »
This article was originally published by Ingrid Freije, Stéphane Lamouche, and Mario Tanguay in Ther Innov Regul Sci. 2019 Jan 7:2168479018811889 under a Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by…
This article was originally published by Ingrid Freije, Stéphane Lamouche, and Mario Tanguay in Ther Innov Regul Sci. 2019 Jan 7:2168479018811889 under a Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by…
Get new actionable insights and updates from BiotechBlog
